Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.449. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01CA211052-03
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
European Commission
Grant: 835297
Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection
National Institutes of Health
Grant: 1U01CA217882-01
The Cancer Target Discovery and Development Network at UCSF
UK Research and Innovation
Grant: NC/S001832/1
Refining the lung cancer mouse model through environmental enrichment
European Commission
Grant: 665233
Super-resolution visualisation and manipulation of metaphase chromosomes
National Institutes of Health
Grant: 5T32HL007185-42
Multidisciplinary Training Program in Lung Disease
National Institutes of Health
Grant: 5P01CA234228-03
APOBEC MUTAGENESIS IN BREAST CANCER
National Institutes of Health
Grant: 1R01CA227807-01
Genomics and Functional Characterization of NF1-mutated Lung Cancer
National Institutes of Health
Grant: 3U54CA224081-01S1
Bay Area Team Against Resistance
European Commission
Grant: 617844
Tumour Heterogeneity and Somatic Evolution of Unstable cancer genomes
National Institutes of Health
Grant: 5R01CA169338-02
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment
Wellcome Trust
Grant: unidentified
unidentified
Fields of Study
Keywords
Sustainable Development Goals